Status of polypharmacy among elderly mentally illness patients
10.3760/cma.j.issn.1674-2907.2019.08.012
- VernacularTitle:老年精神疾病患者多重用药现状研究
- Author:
Jing SHAO
1
;
Xiaoying HOU
;
Tingting HUANG
;
Xia LI
;
Zhiwen WANG
Author Information
1. 北京回龙观医院护理部 100096
- Keywords:
Aged;
Mental disorders;
Adverse Reactions;
Polypharmacy
- From:
Chinese Journal of Modern Nursing
2019;25(8):975-979
- CountryChina
- Language:Chinese
-
Abstract:
Objective? To explore the polypharmacy and drug adverse reactions among elderly mentally illness patients so as to provide a basis for the training of individualized medication observation, nursing and safe medication. Methods? From March to April 2018, we selected 180 patients of geriatrics department at Beijing Huilongguan Hospital and Peking University Sixth Hospital by successive sampling. We collected data involving demographic data, disease data, drug types and names, drug adverse reactions by consulting medical records. Results? Among elderly mentally illness patients, schizophrenia (40.56%) and various types of dementia (40.56%) were the commonest; the number of accompanied diseases was (5.4±2.1) and the top 5 of the commonest was cerebral infarction, cardiovascular disease, hyperlipemia, osteoporosis and hypertension. The kinds of oral medicine were (6.5±2.4); the incidences of polypharmacy and drug adverse reactions were 90.56% and 73.33% respectively. The commonest drug adverse reactions included abnormal liver function (38.33%), constipation (31.67%) and extrapyramidal syndrome (11.67%). Conclusions? The incidence of polypharmacy among elderly mentally illness patients is relatively high accompanied by severe problems. It prompts that psychiatric medical staff should understand and pay more attention to polypharmacy, and provide individualized medication observation and nursing to reduce the adverse effects of polypharmacy on patients.
